Literature DB >> 3772803

Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors.

L P Dwoskin, N R Zahniser.   

Abstract

Conflicting results have been reported for D-2 dopamine (DA) receptor modulation of DA release from rat striatal slices. After systematic examination of the assay conditions used to evoke release of [3H]DA, we report robust modulation of calcium-dependent stimulation-evoked 3H-overflow by D-2 receptors in rat striatal slices preloaded with [3H]DA. In the presence of the DA uptake inhibitor, nomifensine, the amount of 3H-overflow evoked by low numbers (15-30) of pulses was not dependent on the frequency of stimulation (0.25-3.0 Hz). When larger numbers (60-300) of pulses were applied, 3H-overflow was related inversely to the frequency of stimulation. In contrast, 3H-overflow increased linearly as the total number of pulses applied was increased when examined at any of these frequencies. Nomifensine (10 microM) augmented 3H-overflow at each level of stimulation while only slightly increasing spontaneous release. Modulation of evoked 3H-overflow by S-sulpiride, a selective D-2 DA receptor antagonist, was dependent on the number of pulses delivered, rather than on the frequency of stimulation. In contrast, modulation by pergolide, a selective D-2 DA receptor agonist, was dependent on stimulation frequency. S-sulpiride produced greater augmentation of 3H-overflow after delivery of low numbers of pulses in the presence of nomifensine. However, pergolide produced greater inhibition of 3H-overflow at low frequencies of stimulation in the absence of nomifensine. These results indicate that D-2 receptors in rat striatum modulate DA release and are most effective when a low concentration of endogenous DA is present in the synaptic cleft.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3772803

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

1.  Angiotensin AT1 and AT2 receptor antagonists modulate nicotine-evoked [³H]dopamine and [³H]norepinephrine release.

Authors:  Vidya Narayanaswami; Sucharita S Somkuwar; David B Horton; Lisa A Cassis; Linda P Dwoskin
Journal:  Biochem Pharmacol       Date:  2013-07-04       Impact factor: 5.858

2.  Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.

Authors:  D M Weiner; A I Levey; M R Brann
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Transmitter release patterns of noradrenergic, dopaminergic and cholinergic axons in rabbit brain slices during short pulse trains, and the operation of presynaptic autoreceptors.

Authors:  A Mayer; N Limberger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

4.  Novel multifunctional pharmacology of lobinaline, the major alkaloid from Lobelia cardinalis.

Authors:  Dustin P Brown; Dennis T Rogers; Francois Pomerleau; Kirin B Siripurapu; Manish Kulshrestha; Greg A Gerhardt; John M Littleton
Journal:  Fitoterapia       Date:  2016-04-20       Impact factor: 2.882

Review 5.  Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice.

Authors:  T E Koeltzow; M Xu; D C Cooper; X T Hu; S Tonegawa; M E Wolf; F J White
Journal:  J Neurosci       Date:  1998-03-15       Impact factor: 6.167

6.  Behavioral and neurochemical changes in the dopaminergic system after repeated cocaine administration.

Authors:  L H Claye; H C Akunne; M D Davis; S DeMattos; K F Soliman
Journal:  Mol Neurobiol       Date:  1995 Aug-Dec       Impact factor: 5.590

7.  Cyclin-dependent kinase 5 inhibitors: inhibition of dopamine transporter activity.

Authors:  David A Price; Alexander Sorkin; Nancy R Zahniser
Journal:  Mol Pharmacol       Date:  2009-07-23       Impact factor: 4.436

8.  Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices.

Authors:  J L Fitzgerald; J J Reid
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-03       Impact factor: 3.000

9.  Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.

Authors:  Guangrong Zheng; Andrew M Smith; Xiaoqin Huang; Karunai L Subramanian; Kiran B Siripurapu; Agripina Deaciuc; Chang-Guo Zhan; Linda P Dwoskin
Journal:  J Med Chem       Date:  2013-02-18       Impact factor: 7.446

10.  Differences in evoked dopamine efflux in rat caudate putamen, nucleus accumbens and tuberculum olfactorium in the absence of uptake inhibition: influence of autoreceptors.

Authors:  S J Trout; Z L Kruk
Journal:  Br J Pharmacol       Date:  1992-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.